INTERESTED IN THIS RESEARCH?
Contact our analysts for inquiries, samples, and expert insights.
REPORT OUTLOOK
| Market Size | CAGR | Dominating Region |
|---|---|---|
| USD 8.27 billion by 2029 | 7.6% | North America |
| By Component | By Technology | By Application |
|---|---|---|
|
|
|
SCOPE OF THE REPORT
Flow Cytometry Market Overview
The Flow cytometry market is expected to grow at 7.6% CAGR from 2022 to 2029. It is expected to reach above USD 8.27 billion by 2029 from USD 4.28 billion in 2020.
Flow cytometry is a widely used method for analyzing the expression of cell surface and intracellular molecules, characterizing and defining different cell types in a heterogeneous cell population, assessing the purity of isolated subpopulations, and analyzing cell size and volume. It allows simultaneous multi-parameter analysis of single cells. It is mostly used to assess the amount of fluorescence produced by fluorescently-labeled antibodies that are used to detect proteins or ligands that bind to particular compounds found in cells, such as DNA when propidium iodide is present. Making a single-cell suspension from tissue or cell culture materials is the staining process. The cells are then treated with unlabeled or fluorescently-labeled antibodies in tubes or microtiter plates before being evaluated on a flow cytometer.
| ATTRIBUTE | DETAILS |
| Study period | 2020-2029 |
| Base year | 2022 |
| Estimated year | 2022 |
| Forecasted year | 2022-2029 |
| Historical period | 2018-2020 |
| Unit | Value (USD BILLION) |
| Segmentation | By Component, By Technology, By Function, By End-user, By Region |
| By Component
 |
|
| By Technology
 |
|
| By Application
 |
|
| By End-user
 |
|
| By Region
 |
|
High demand for flow cytometry instruments is also a result of growing R&D expenditures in biotechnology, life science, and biopharmaceutical research activities. The development of microfluidic flow cytometry for Point-of-Care (POC) testing is one example of the new and improved analytical instruments being introduced by technological improvements in the technique.
Flow cytometry, an analytical tool used in the measurement and analysis of physical characteristics of cells or particles, has emerged as a key tool for safety and exploratory purposes during the drug discovery and development processes. Its emergence as a crucial tool is largely due to technology’s capacity to quickly examine a huge number of particles and produce statistically reliable information on the cell population. The main drivers of the market expansion are the expanding use of flow cytometry in clinical research and the growing usage of the technique in stem cell research. Additionally, its multi-parametric methodology is aiding flow cytometry’s adoption in the processes of drug discovery and development.
The expanding emphasis on immunology and immuno-oncology research, the rising acceptance of flow cytometry techniques in research activities and clinical trials, and the expanding technical advancements are propelling the expansion of the global flow cytometry market. As the HIV population increases globally, there is an increasing need for diagnostic tools like flow cytometry.
The bioengineering industry has experienced tremendous expansion thanks to its applications in a number of fields, including drug discovery, cell culture, and stem cell therapy which is creating more opportunities for the flow cytometry market. The market is also predicted to grow due to the increase in the prevalence of infectious diseases and the growing demand for quick and precise cancer prognostic tools. In general, it is projected that expanding applications in the life science sector will fuel greater demand. The rise in healthcare organizations that support the adoption of high-quality treatments and medical procedures is more likely to be the root of the market’s expansion.
Additionally, changing the flow cytometry region to minimize conflicts with several different antibodies within a flow cytometry panel has been increasingly popular in recent years. Recombinant antibodies have reduced the cost of flow cytometry by lowering the high background that frequently occurs when antibodies attach to Fc receptors. As a result, the development of recombinant DNA technology for antibody manufacturing in flow cytometry has opened up a variety of new commercial potential.
The availability of superior and more affordable substitutes poses a substantial obstacle to the market for flow cytometry. These substitutes include ELISA and radioimmunoassay. ELISA and radioimmunoassay are less expensive and easier to use than flow cytometry, despite the fact that all three methods—flow cytometry, ELISA, and radioimmunoassay—help to diagnose HIV by locating “problem cells” amid a population of cells. It is anticipated that there would be an increase in the prevalence of chronic diseases like cancer and HIV, which will enhance the usage of flow cytometry in diagnostic applications. The development of the flow cytometry market, on the other hand, is predicted to be hampered by problems such as expensive equipment and reagents, a lack of awareness among potential end users, and a lack of technical proficiency.
The COVID-19 pandemic had a positive effect on the prospects for the flow cytometry business during the initial COVID-19 epidemic. The rising application of reagents in research and clinical trials has boosted the market share of flow cytometry reagents and thus the use of flow cytometry technology. For instance, in March 2020, Cytek Biosciences Inc. provided support to doctors and researchers throughout the globe who were examining the effects of the COVID-19 virus on human immune systems. The use of flow cytometry-based techniques for COVID-19 diagnostics and disease surveillance has aided the industry’s expansion. Furthermore, the pandemic has fueled innovation in the flow cytometry space, as evidenced by the introduction of new products in this field.
Flow Cytometry Market Segment Analysis
The flow cytometry market is segmented based on component, technology, application, end-user and region, global trends and forecast.
By component the market is bifurcated into instruments, Reagents and Consumables, Software, and Service; by Technology the market is bifurcated into Cell based and Bead based; by Application the market is bifurcated into Academic & Clinical applications and Diagnostic application; by End-user the market is bifurcated into Hospitals, Medical schools and clinical testing labs, Commercial organizations, Academic institutions, Others and Region.
Due to the development of novel instrument designs, the necessity for highly effective replacement components, applications in the treatment of emerging diseases, and an increase in research and advancements in flow cytometry techniques, the instruments segment held the largest market share in 2021. Reagents and consumables are crucial for flow cytometry analysis; hence they are predicted to overtake all other segments. Due to the combination of imaging capabilities and reagent consumption for enhancing the instrument performance and making it more affordable for emerging economies, the market share for flow cytometry reagents is anticipated to increase.
In 2021, the technology segment was led by the cell-based flow cytometry, which brought in more than 77.25% of the total revenue. Its dominance is influenced by rising demand for early diagnosis and growing understanding of the advantages of cell-based assays. The adoption is also anticipated to be fueled in the future by technological developments in cell-based assays, such as innovation in software, instruments, algorithms, affinity reagents, and labels. Bead-based flow cytometry is used to measure intracellular soluble proteins such as growth factors, cytokines, chemokines, and phosphorylated cell signaling proteins. The high-throughput flow cytometry technique is thought to be the best tool for performing multiplex bead-based assays. During the forecast period, the bead-based assay segment is expected to grow at a significant CAGR of more than.
Academic & clinical applications segment accounted for a significant share of the market share in the flow cytometry market in 2021, owing to an increase in research of academic & clinical applications of flow cytometry. However, due to the increased use of technology in diagnostic applications, the diagnostic applications segment is expected to grow at a rapid pace.
In 2021, the academic institutes segment had a higher revenue share than other segments in terms of end-users. In cell biology and molecular diagnostic studies, the technique is used to measure cell parameters such as physical properties of cells, recognition of biomarkers via specific antibodies, cell type, cell lineage, and maturation stage. This technology can be used in a variety of educational settings, including molecular biology, immunology, pathology, plant biology, and marine biology. With increased R&D activities, the segment is expected to grow significantly during the forecast period.
Flow Cytometry Market Key Players
The flow cytometry market key players include Agilent Technologies Inc., Becton Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories Inc., Danaher Corporation, DiaSorin S.p.A., Miltenyi Biotec Inc., Sartorius AG, Sysmex Corporation, Thermo Fisher Scientific Inc., and others.
11 January 2023: BD (Becton, Dickinson and Company), a leading global medical technology company, introduced a new, robotic track system for the BD Kiestra microbiology laboratory solution that automates lab specimen processing, which may help to reduce manual labor and wait time for results.
24 January 2023: Â Â As part of a global, multiyear agreement, Thermo Fisher Scientific today announced it is working with AstraZeneca to develop a solid tissue and blood-based companion diagnostic (CDx) test for Tagrisso (osimertinib).
Who Should Buy? Or Key Stakeholders
- Medical Technology Companies
- Scientific Research & Development
- Medical Devices Manufacturers
- End-users
- Regulatory Authorities
- Others
Flow Cytometry Market Regional Analysis
The flow cytometry market by region includes North America, Asia-Pacific (APAC), Europe, South America, and Middle East & Africa (MEA).
- North America: includes the US, Canada, Mexico
- Asia Pacific: includes China, Japan, South Korea, India, Australia, and Rest of APAC
- Europe: includes UK, Germany, France, Italy, Spain, Russia, and Rest of Europe
- South America: includes Brazil, Argentina, and Rest of South America
- Middle East & Africa: includes UAE, South Africa, Saudi Arabia and Rest of MEA
The flow cytometry market is dominated by North America, which also generates the highest revenue. Throughout the length of the forecast, this region is expected to dominate this market. This result is attributable to the U.S.’s substantial investment in healthcare, highly developed healthcare infrastructure, and widespread usage of flow cytometry technology. Additionally, there is a considerable need for flow cytometry equipment for research needs due to the highly expected research activities by pharmaceutical corporations and research colleges.
The second-largest flow cytometry market is anticipated to be in Europe. Government funding and support for R&D initiatives, increased public knowledge of healthcare diagnostics, and an increase in the number of cancer patients in the area are all factors contributing to the market growth in this region. Additionally, the pharmaceutical business is expanding its research and development efforts, which is boosting the market in this area.
Due to the rising prevalence of autoimmune diseases, rising healthcare awareness, rising investments and collaborative activities in the healthcare sector, as well as expansions by market players in the region, Asia-Pacific is anticipated to experience the fastest growth in the flow cytometry market during the forecast period.
Key Market Segments: Flow cytometry market
Flow Cytometry Market By Component, 2020-2029, (USD Billion)
- Instruments
- Reagents And Consumables
- Software
- Service
Flow Cytometry Market By Technology, 2020-2029, (USD Billion)
- Cell Based
- Bead Based
Flow Cytometry Market By Application, 2020-2029, (USD Billion)
- Academic & Clinical Applications
- Diagnostic Application
Flow Cytometry Market By End-User, 2020-2029, (USD Billion)
- Hospitals
- Medical Schools And Clinical Testing Labs
- Commercial Organizations
- Academic Institutions
- Others
Flow Cytometry Market by Region, 2020-2029, (USD Billion)
- North America
- Asia Pacific
- Europe
- South America
- Middle East And Africa
Important Countries In All Regions Are Covered.
Exactitude Consultancy Services Key Objectives:
- Increasing sales and market share
- Developing new technology
- Improving profitability
- Entering new markets
- Enhancing brand reputation
Key Question Answered
- What is the expected growth rate of the Flow cytometry market over the next 7 years?
- Who are the major players in the Flow cytometry market and what is their market share?
- What are the opportunities for growth in emerging markets such as Asia-Pacific, Middle East, and Africa?
- How is the economic environment affecting the Flow cytometry market, including factors such as interest rates, inflation, and exchange rates?
- What is the expected impact of government policies and regulations on the Flow cytometry market?
- What is the current and forecasted size and growth rate of the global Flow cytometry market?
- What are the key drivers of growth in the Flow cytometry market?
- Who are the major players in the market and what is their market share?
- What are the distribution channels and supply chain dynamics in the Flow cytometry market?
- What are the technological advancements and innovations in the Flow cytometry market and their impact on product development and growth?
- What are the regulatory considerations and their impact on the market?
- What are the challenges faced by players in the Flow cytometry market and how are they addressing these challenges?
- What are the opportunities for growth and expansion in the Flow cytometry market?
- What are the service offerings and specifications of leading players in the market?
Table of Content
- INTRODUCTION
- MARKET DEFINITION
- MARKET SEGMENTATION
- RESEARCH TIMELINES
- ASSUMPTIONS AND LIMITATIONS
- RESEARCH METHODOLOGY
- DATA MINING
- SECONDARY RESEARCH
- PRIMARY RESEARCH
- SUBJECT-MATTER EXPERTS’ ADVICE
- QUALITY CHECKS
- FINAL REVIEW
- DATA TRIANGULATION
- BOTTOM-UP APPROACH
- TOP-DOWN APPROACH
- RESEARCH FLOW
- DATA SOURCES
- DATA MINING
- EXECUTIVE SUMMARY
- MARKET OVERVIEW
- GLOBAL FLOW CYTOMETRY MARKET OUTLOOK
- MARKET DRIVERS
- MARKET RESTRAINTS
- MARKET OPPORTUNITIES
- IMPACT OF COVID-19 ON FLOW CYTOMETRY MARKET
- PORTER’S FIVE FORCES MODEL
- THREAT FROM NEW ENTRANTS
- THREAT FROM SUBSTITUTES
- BARGAINING POWER OF SUPPLIERS
- BARGAINING POWER OF CUSTOMERS
- DEGREE OF COMPETITION
- INDUSTRY VALUE CHAIN ANALYSIS
- GLOBAL FLOW CYTOMETRY MARKET OUTLOOK
- GLOBAL FLOW CYTOMETRY MARKET BY COMPONENT (USD BILLION), 2020-2029
- INSTRUMENTS
- REAGENTS AND CONSUMABLES
- SOFTWARE
- SERVICE
- GLOBAL FLOW CYTOMETRY MARKET BY TECHNOLOGY (USD BILLION), 2020-2029
- CELL BASED
- BEAD BASED
- GLOBAL FLOW CYTOMETRY MARKET BY APPLICATION (USD BILLION), 2020-2029
- ACADEMIC & CLINICAL APPLICATIONS
- DIAGNOSTIC APPLICATION
- GLOBAL FLOW CYTOMETRY MARKET BY END-USER (USD BILLION), 2020-2029
- HOSPITALS
- MEDICAL SCHOOLS AND CLINICAL TESTING LABS
- COMMERCIAL ORGANIZATIONS
- ACADEMIC INSTITUTIONS
- OTHERS
- GLOBAL FLOW CYTOMETRY MARKET BY REGION (USD BILLION), 2020-2029
- NORTH AMERICA
- US
- CANADA
- MEXICO
- SOUTH AMERICA
- BRAZIL
- ARGENTINA
- COLOMBIA
- REST OF SOUTH AMERICA
- EUROPE
- GERMANY
- UK
- FRANCE
- ITALY
- SPAIN
- RUSSIA
- REST OF EUROPE
- ASIA PACIFIC
- INDIA
- CHINA
- JAPAN
- SOUTH KOREA
- AUSTRALIA
- REST OF ASIA PACIFIC
- MIDDLE EAST AND AFRICA
- UAE
- SOUTH AFRICA
- SAUDI ARABIA
- REST OF MIDDLE EAST AND AFRICA
- NORTH AMERICA
- COMPANY PROFILES* (BUSINESS OVERVIEW, COMPANY SNAPSHOT, PRODUCTS OFFERED, RECENT DEVELOPMENTS)
- AGILENT TECHNOLOGIES INC.
- BECTON DICKINSON AND COMPANY
- BIOMÉRIEUX SA
- BIO-RAD LABORATORIES INC.
- DANAHER CORPORATION
- DIASORIN S.P.A.
- MILTENYI BIOTEC INC.
- SARTORIUS AG
- SYSMEX CORPORATION
- THERMO FISHER SCIENTIFIC INC. *THE COMPANY LIST IS INDICATIVE
LIST OF TABLES
TABLE 1Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL FLOW CYTOMETRY MARKET BY COMPONENT (USD BILLION), 2020-2029
TABLE 2Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL FLOW CYTOMETRY MARKET BY TECHNOLOGY (USD BILLION), 2020-2029
TABLE 3Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL FLOW CYTOMETRY MARKET BY APPLICATION (USD BILLION), 2020-2029
TABLE 4Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL FLOW CYTOMETRY MARKET BY END-USER (USD BILLION), 2020-2029
TABLE 5Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL FLOW CYTOMETRY MARKET BY REGION (USD BILLION), 2020-2029
TABLE 6Â Â Â Â Â Â Â Â Â Â Â Â Â NORTH AMERICA FLOW CYTOMETRY MARKET BY COMPONENT (USD BILLION), 2020-2029
TABLE 7Â Â Â Â Â Â Â Â Â Â Â Â Â NORTH AMERICA FLOW CYTOMETRY MARKET BY TECHNOLOGY (USD BILLION), 2020-2029
TABLE 8Â Â Â Â Â Â Â Â Â Â Â Â Â NORTH AMERICA FLOW CYTOMETRY MARKET BY APPLICATION (USD BILLION), 2020-2029
TABLE 9Â Â Â Â Â Â Â Â Â Â Â Â Â NORTH AMERICA FLOW CYTOMETRY MARKET BY END-USER (USD BILLION), 2020-2029
TABLE 10Â Â Â Â Â Â Â Â Â Â Â NORTH AMERICA FLOW CYTOMETRY MARKET BY COUNTRY (USD BILLION), 2020-2029
TABLE 11Â Â Â Â Â Â Â Â Â Â Â US FLOW CYTOMETRY MARKET BY COMPONENT (USD BILLION), 2020-2029
TABLE 12Â Â Â Â Â Â Â Â Â Â Â US FLOW CYTOMETRY MARKET BY TECHNOLOGY (USD BILLION), 2020-2029
TABLE 13Â Â Â Â Â Â Â Â Â Â Â US FLOW CYTOMETRY MARKET BY APPLICATION (USD BILLION), 2020-2029
TABLE 14Â Â Â Â Â Â Â Â Â Â Â US FLOW CYTOMETRY MARKET BY END-USER (USD BILLION), 2020-2029
TABLE 15Â Â Â Â Â Â Â Â Â Â Â CANADA FLOW CYTOMETRY MARKET BY COMPONENT (BILLION), 2020-2029
TABLE 16Â Â Â Â Â Â Â Â Â Â Â CANADA FLOW CYTOMETRY MARKET BY TECHNOLOGY (USD BILLION), 2020-2029
TABLE 17Â Â Â Â Â Â Â Â Â Â Â CANADA FLOW CYTOMETRY MARKET BY APPLICATION (USD BILLION), 2020-2029
TABLE 18Â Â Â Â Â Â Â Â Â Â Â CANADA FLOW CYTOMETRY MARKET BY END-USER (USD BILLION), 2020-2029
TABLE 19Â Â Â Â Â Â Â Â Â Â Â MEXICO FLOW CYTOMETRY MARKET BY COMPONENT (USD BILLION), 2020-2029
TABLE 20Â Â Â Â Â Â Â Â Â Â Â MEXICO FLOW CYTOMETRY MARKET BY TECHNOLOGY (USD BILLION), 2020-2029
TABLE 21Â Â Â Â Â Â Â Â Â Â Â MEXICO FLOW CYTOMETRY MARKET BY APPLICATION (USD BILLION), 2020-2029
TABLE 22Â Â Â Â Â Â Â Â Â Â Â MEXICO FLOW CYTOMETRY MARKET BY END-USER (USD BILLION), 2020-2029
TABLE 23Â Â Â Â Â Â Â Â Â Â Â REST OF NORTH AMERICA FLOW CYTOMETRY MARKET BY COMPONENT (USD BILLION), 2020-2029
TABLE 24Â Â Â Â Â Â Â Â Â Â Â REST OF NORTH AMERICA FLOW CYTOMETRY MARKET BY TECHNOLOGY (USD BILLION), 2020-2029
TABLE 25Â Â Â Â Â Â Â Â Â Â Â REST OF NORTH AMERICA FLOW CYTOMETRY MARKET BY APPLICATION (USD BILLION), 2020-2029
TABLE 26Â Â Â Â Â Â Â Â Â Â Â REST OF NORTH AMERICA FLOW CYTOMETRY MARKET BY END-USER (USD BILLION), 2020-2029
TABLE 27Â Â Â Â Â Â Â Â Â Â Â SOUTH AMERICA FLOW CYTOMETRY MARKET BY COMPONENT (USD BILLION), 2020-2029
TABLE 28Â Â Â Â Â Â Â Â Â Â Â SOUTH AMERICA FLOW CYTOMETRY MARKET BY TECHNOLOGY (USD BILLION), 2020-2029
TABLE 29Â Â Â Â Â Â Â Â Â Â Â SOUTH AMERICA FLOW CYTOMETRY MARKET BY APPLICATION (USD BILLION), 2020-2029
TABLE 30Â Â Â Â Â Â Â Â Â Â Â SOUTH AMERICA FLOW CYTOMETRY MARKET BY END-USER (USD BILLION), 2020-2029
TABLE 31Â Â Â Â Â Â Â Â Â Â Â SOUTH AMERICA FLOW CYTOMETRY MARKET BY COUNTRY (USD BILLION), 2020-2029
TABLE 32Â Â Â Â Â Â Â Â Â Â Â BRAZIL FLOW CYTOMETRY MARKET BY COMPONENT (USD BILLION), 2020-2029
TABLE 33Â Â Â Â Â Â Â Â Â Â Â BRAZIL FLOW CYTOMETRY MARKET BY TECHNOLOGY (USD BILLION), 2020-2029
TABLE 34Â Â Â Â Â Â Â Â Â Â Â BRAZIL FLOW CYTOMETRY MARKET BY APPLICATION (USD BILLION), 2020-2029
TABLE 35Â Â Â Â Â Â Â Â Â Â Â BRAZIL FLOW CYTOMETRY MARKET BY END-USER (USD BILLION), 2020-2029
TABLE 36Â Â Â Â Â Â Â Â Â Â Â ARGENTINA FLOW CYTOMETRY MARKET BY COMPONENT (USD BILLION), 2020-2029
TABLE 37Â Â Â Â Â Â Â Â Â Â Â ARGENTINA FLOW CYTOMETRY MARKET BY TECHNOLOGY (USD BILLION), 2020-2029
TABLE 38Â Â Â Â Â Â Â Â Â Â Â ARGENTINA FLOW CYTOMETRY MARKET BY APPLICATION (USD BILLION), 2020-2029
TABLE 39Â Â Â Â Â Â Â Â Â Â Â ARGENTINA FLOW CYTOMETRY MARKET BY END-USER (USD BILLION), 2020-2029
TABLE 40Â Â Â Â Â Â Â Â Â Â Â COLOMBIA FLOW CYTOMETRY MARKET BY COMPONENT (USD BILLION), 2020-2029
TABLE 41Â Â Â Â Â Â Â Â Â Â Â COLOMBIA FLOW CYTOMETRY MARKET BY TECHNOLOGY (USD BILLION), 2020-2029
TABLE 42Â Â Â Â Â Â Â Â Â Â Â COLOMBIA FLOW CYTOMETRY MARKET BY APPLICATION (USD BILLION), 2020-2029
TABLE 43Â Â Â Â Â Â Â Â Â Â Â COLOMBIA FLOW CYTOMETRY MARKET BY END-USER (USD BILLION), 2020-2029
TABLE 44Â Â Â Â Â Â Â Â Â Â Â REST OF SOUTH AMERICA FLOW CYTOMETRY MARKET BY COMPONENT (USD BILLION), 2020-2029
TABLE 45Â Â Â Â Â Â Â Â Â Â Â REST OF SOUTH AMERICA FLOW CYTOMETRY MARKET BY TECHNOLOGY (USD BILLION), 2020-2029
TABLE 46Â Â Â Â Â Â Â Â Â Â Â REST OF SOUTH AMERICA FLOW CYTOMETRY MARKET BY APPLICATION (USD BILLION), 2020-2029
TABLE 47Â Â Â Â Â Â Â Â Â Â Â REST OF SOUTH AMERICA FLOW CYTOMETRY MARKET BY END-USER (USD BILLION), 2020-2029
TABLE 48Â Â Â Â Â Â Â Â Â Â Â ASIA -PACIFIC FLOW CYTOMETRY MARKET BY COMPONENT (USD BILLION), 2020-2029
TABLE 49Â Â Â Â Â Â Â Â Â Â Â ASIA -PACIFIC FLOW CYTOMETRY MARKET BY TECHNOLOGY (USD BILLION), 2020-2029
TABLE 50Â Â Â Â Â Â Â Â Â Â Â ASIA -PACIFIC FLOW CYTOMETRY MARKET BY APPLICATION (USD BILLION), 2020-2029
TABLE 51Â Â Â Â Â Â Â Â Â Â Â ASIA -PACIFIC FLOW CYTOMETRY MARKET BY END-USER (USD BILLION), 2020-2029
TABLE 52Â Â Â Â Â Â Â Â Â Â Â ASIA -PACIFIC FLOW CYTOMETRY MARKET BY COUNTRY (USD BILLION), 2020-2029
TABLE 53Â Â Â Â Â Â Â Â Â Â Â INDIA FLOW CYTOMETRY MARKET BY COMPONENT (USD BILLION), 2020-2029
TABLE 54Â Â Â Â Â Â Â Â Â Â Â INDIA FLOW CYTOMETRY MARKET BY TECHNOLOGY (USD BILLION), 2020-2029
TABLE 55Â Â Â Â Â Â Â Â Â Â Â INDIA FLOW CYTOMETRY MARKET BY APPLICATION (USD BILLION), 2020-2029
TABLE 56Â Â Â Â Â Â Â Â Â Â Â INDIA FLOW CYTOMETRY MARKET BY END-USER (USD BILLION), 2020-2029
TABLE 57Â Â Â Â Â Â Â Â Â Â Â CHINA FLOW CYTOMETRY MARKET BY COMPONENT (USD BILLION), 2020-2029
TABLE 58Â Â Â Â Â Â Â Â Â Â Â CHINA FLOW CYTOMETRY MARKET BY TECHNOLOGY (USD BILLION), 2020-2029
TABLE 59Â Â Â Â Â Â Â Â Â Â Â CHINA FLOW CYTOMETRY MARKET BY APPLICATION (USD BILLION), 2020-2029
TABLE 60Â Â Â Â Â Â Â Â Â Â Â CHINA FLOW CYTOMETRY MARKET BY END-USER (USD BILLION), 2020-2029
TABLE 61Â Â Â Â Â Â Â Â Â Â Â JAPAN FLOW CYTOMETRY MARKET BY COMPONENT (USD BILLION), 2020-2029
TABLE 62Â Â Â Â Â Â Â Â Â Â Â JAPAN FLOW CYTOMETRY MARKET BY TECHNOLOGY (USD BILLION), 2020-2029
TABLE 63Â Â Â Â Â Â Â Â Â Â Â JAPAN FLOW CYTOMETRY MARKET BY APPLICATION (USD BILLION), 2020-2029
TABLE 64Â Â Â Â Â Â Â Â Â Â Â JAPAN FLOW CYTOMETRY MARKET BY END-USER (USD BILLION), 2020-2029
TABLE 65Â Â Â Â Â Â Â Â Â Â Â SOUTH KOREA FLOW CYTOMETRY MARKET BY COMPONENT (USD BILLION), 2020-2029
TABLE 66Â Â Â Â Â Â Â Â Â Â Â SOUTH KOREA FLOW CYTOMETRY MARKET BY TECHNOLOGY (USD BILLION), 2020-2029
TABLE 67Â Â Â Â Â Â Â Â Â Â Â SOUTH KOREA FLOW CYTOMETRY MARKET BY APPLICATION (USD BILLION), 2020-2029
TABLE 68Â Â Â Â Â Â Â Â Â Â Â SOUTH KOREA FLOW CYTOMETRY MARKET BY END-USER (USD BILLION), 2020-2029
TABLE 69Â Â Â Â Â Â Â Â Â Â Â AUSTRALIA FLOW CYTOMETRY MARKET BY COMPONENT (USD BILLION), 2020-2029
TABLE 70Â Â Â Â Â Â Â Â Â Â Â AUSTRALIA HYBRID APPLICATIONBY TECHNOLOGY (USD BILLION), 2020-2029
TABLE 71Â Â Â Â Â Â Â Â Â Â Â AUSTRALIA FLOW CYTOMETRY MARKET BY APPLICATION (USD BILLION), 2020-2029
TABLE 72Â Â Â Â Â Â Â Â Â Â Â AUSTRALIA FLOW CYTOMETRY MARKET BY END-USER (USD BILLION), 2020-2029
TABLE 73Â Â Â Â Â Â Â Â Â Â Â REST OF ASIA PACIFIC FLOW CYTOMETRY MARKET BY COMPONENT (USD BILLION), 2020-2029
TABLE 74Â Â Â Â Â Â Â Â Â Â Â REST OF ASIA PACIFIC HYBRID APPLICATIONBY TECHNOLOGY (USD BILLION), 2020-2029
TABLE 75Â Â Â Â Â Â Â Â Â Â Â REST OF ASIA PACIFIC FLOW CYTOMETRY MARKET BY APPLICATION (USD BILLION), 2020-2029
TABLE 76Â Â Â Â Â Â Â Â Â Â Â REST OF ASIA PACIFIC FLOW CYTOMETRY MARKET BY END-USER (USD BILLION), 2020-2029
TABLE 77Â Â Â Â Â Â Â Â Â Â Â EUROPE FLOW CYTOMETRY MARKET BY COMPONENT (USD BILLION), 2020-2029
TABLE 78Â Â Â Â Â Â Â Â Â Â Â EUROPE FLOW CYTOMETRY MARKET BY TECHNOLOGY (USD BILLION), 2020-2029
TABLE 79Â Â Â Â Â Â Â Â Â Â Â EUROPE FLOW CYTOMETRY MARKET BY APPLICATION (USD BILLION), 2020-2029
TABLE 80Â Â Â Â Â Â Â Â Â Â Â EUROPE FLOW CYTOMETRY MARKET BY END-USER (USD BILLION), 2020-2029
TABLE 81Â Â Â Â Â Â Â Â Â Â Â EUROPE FLOW CYTOMETRY MARKET BY COUNTRY (USD BILLION), 2020-2029
TABLE 82Â Â Â Â Â Â Â Â Â Â Â GERMANY FLOW CYTOMETRY MARKET BY COMPONENT (USD BILLION), 2020-2029
TABLE 83Â Â Â Â Â Â Â Â Â Â Â GERMANY FLOW CYTOMETRY MARKET BY TECHNOLOGY (USD BILLION), 2020-2029
TABLE 84Â Â Â Â Â Â Â Â Â Â Â GERMANY FLOW CYTOMETRY MARKET BY APPLICATION (USD BILLION), 2020-2029
TABLE 85Â Â Â Â Â Â Â Â Â Â Â GERMANY FLOW CYTOMETRY MARKET BY END-USER (USD BILLION), 2020-2029
TABLE 86Â Â Â Â Â Â Â Â Â Â Â UK FLOW CYTOMETRY MARKET BY COMPONENT (USD BILLION), 2020-2029
TABLE 87Â Â Â Â Â Â Â Â Â Â Â UK FLOW CYTOMETRY MARKET BY TECHNOLOGY (USD BILLION), 2020-2029
TABLE 88Â Â Â Â Â Â Â Â Â Â Â UK FLOW CYTOMETRY MARKET BY APPLICATION (USD BILLION), 2020-2029
TABLE 89Â Â Â Â Â Â Â Â Â Â Â UK FLOW CYTOMETRY MARKET BY END-USER (USD BILLION), 2020-2029
TABLE 90Â Â Â Â Â Â Â Â Â Â Â FRANCE FLOW CYTOMETRY MARKET BY COMPONENT (USD BILLION), 2020-2029
TABLE 91Â Â Â Â Â Â Â Â Â Â Â FRANCE FLOW CYTOMETRY MARKET BY TECHNOLOGY (USD BILLION), 2020-2029
TABLE 92Â Â Â Â Â Â Â Â Â Â Â FRANCE FLOW CYTOMETRY MARKET BY APPLICATION (USD BILLION), 2020-2029
TABLE 93Â Â Â Â Â Â Â Â Â Â Â FRANCE FLOW CYTOMETRY MARKET BY END-USER (USD BILLION), 2020-2029
TABLE 94Â Â Â Â Â Â Â Â Â Â Â ITALY FLOW CYTOMETRY MARKET BY COMPONENT (USD BILLION), 2020-2029
TABLE 95Â Â Â Â Â Â Â Â Â Â Â ITALY FLOW CYTOMETRY MARKET BY TECHNOLOGY (USD BILLION), 2020-2029
TABLE 96Â Â Â Â Â Â Â Â Â Â Â ITALY FLOW CYTOMETRY MARKET BY APPLICATION (USD BILLION), 2020-2029
TABLE 97Â Â Â Â Â Â Â Â Â Â Â ITALY FLOW CYTOMETRY MARKET BY END-USER (USD BILLION), 2020-2029
TABLE 98Â Â Â Â Â Â Â Â Â Â Â SPAIN FLOW CYTOMETRY MARKET BY COMPONENT (USD BILLION), 2020-2029
TABLE 99Â Â Â Â Â Â Â Â Â Â Â SPAIN FLOW CYTOMETRY MARKET BY TECHNOLOGY (USD BILLION), 2020-2029
TABLE 100Â Â Â Â Â Â Â Â Â SPAIN FLOW CYTOMETRY MARKET BY APPLICATION (USD BILLION), 2020-2029
TABLE 101Â Â Â Â Â Â Â Â Â SPAIN FLOW CYTOMETRY MARKET BY END-USER (USD BILLION), 2020-2029
TABLE 102Â Â Â Â Â Â Â Â Â RUSSIA FLOW CYTOMETRY MARKET BY COMPONENT (USD BILLION), 2020-2029
TABLE 103Â Â Â Â Â Â Â Â Â RUSSIA FLOW CYTOMETRY MARKET BY TECHNOLOGY (USD BILLION), 2020-2029
TABLE 104Â Â Â Â Â Â Â Â Â RUSSIA FLOW CYTOMETRY MARKET BY APPLICATION (USD BILLION), 2020-2029
TABLE 105Â Â Â Â Â Â Â Â Â RUSSIA FLOW CYTOMETRY MARKET BY END-USER (USD BILLION), 2020-2029
TABLE 106Â Â Â Â Â Â Â Â Â REST OF EUROPE FLOW CYTOMETRY MARKET BY COMPONENT (USD BILLION), 2020-2029
TABLE 107Â Â Â Â Â Â Â Â Â REST OF EUROPE FLOW CYTOMETRY MARKET BY TECHNOLOGY (USD BILLION), 2020-2029
TABLE 108Â Â Â Â Â Â Â Â Â REST OF EUROPE FLOW CYTOMETRY MARKET BY APPLICATION (USD BILLION), 2020-2029
TABLE 109Â Â Â Â Â Â Â Â Â REST OF EUROPE FLOW CYTOMETRY MARKET BY END-USER (USD BILLION), 2020-2029
TABLE 110Â Â Â Â Â Â Â Â Â MIDDLE EAST AND AFRICA FLOW CYTOMETRY MARKET BY COMPONENT (USD BILLION), 2020-2029
TABLE 111Â Â Â Â Â Â Â Â Â MIDDLE EAST AND AFRICA FLOW CYTOMETRY MARKET BY TECHNOLOGY (USD BILLION), 2020-2029
TABLE 112Â Â Â Â Â Â Â Â Â MIDDLE EAST AND AFRICA FLOW CYTOMETRY MARKET BY APPLICATION (USD BILLION), 2020-2029
TABLE 113Â Â Â Â Â Â Â Â Â MIDDLE EAST AND AFRICA FLOW CYTOMETRY MARKET BY END-USER (USD BILLION), 2020-2029
TABLE 114Â Â Â Â Â Â Â Â Â MIDDLE EAST ABD AFRICA FLOW CYTOMETRY MARKET BY COUNTRY (USD BILLION), 2020-2029
TABLE 115Â Â Â Â Â Â Â Â Â UAE FLOW CYTOMETRY MARKET BY COMPONENT (USD BILLION), 2020-2029
TABLE 116Â Â Â Â Â Â Â Â Â UAE FLOW CYTOMETRY MARKET BY TECHNOLOGY (USD BILLION), 2020-2029
TABLE 117Â Â Â Â Â Â Â Â Â UAE FLOW CYTOMETRY MARKET BY APPLICATION (USD BILLION), 2020-2029
TABLE 118Â Â Â Â Â Â Â Â Â UAE FLOW CYTOMETRY MARKET BY END-USER (USD BILLION), 2020-2029
TABLE 119Â Â Â Â Â Â Â Â Â SAUDI ARABIA FLOW CYTOMETRY MARKET BY COMPONENT (USD BILLION), 2020-2029
TABLE 120Â Â Â Â Â Â Â Â Â SAUDI ARABIA FLOW CYTOMETRY MARKET BY TECHNOLOGY (USD BILLION), 2020-2029
TABLE 121Â Â Â Â Â Â Â Â Â SAUDI ARABIA FLOW CYTOMETRY MARKET BY APPLICATION (USD BILLION), 2020-2029
TABLE 122Â Â Â Â Â Â Â Â Â SAUDI ARABIA FLOW CYTOMETRY MARKET BY END-USER (USD BILLION), 2020-2029
TABLE 123Â Â Â Â Â Â Â Â Â SOUTH AFRICA FLOW CYTOMETRY MARKET BY COMPONENT (USD BILLION), 2020-2029
TABLE 124Â Â Â Â Â Â Â Â Â SOUTH AFRICA FLOW CYTOMETRY MARKET BY TECHNOLOGY (USD BILLION), 2020-2029
TABLE 125Â Â Â Â Â Â Â Â Â SOUTH AFRICA FLOW CYTOMETRY MARKET BY APPLICATION (USD BILLION), 2020-2029
TABLE 126Â Â Â Â Â Â Â Â Â SOUTH AFRICA FLOW CYTOMETRY MARKET BY END-USER (USD BILLION), 2020-2029
TABLE 127Â Â Â Â Â Â Â Â Â REST OF MIDDLE EAST AND AFRICA FLOW CYTOMETRY MARKET BY COMPONENT (USD BILLION), 2020-2029
TABLE 128Â Â Â Â Â Â Â Â Â REST OF MIDDLE EAST AND AFRICA FLOW CYTOMETRY MARKET BY TECHNOLOGY (USD BILLION), 2020-2029
TABLE 129Â Â Â Â Â Â Â Â Â REST OF MIDDLE EAST AND AFRICA FLOW CYTOMETRY MARKET BY APPLICATION (USD BILLION), 2020-2029
TABLE 130Â Â Â Â Â Â Â Â Â REST OF MIDDLE EAST AND AFRICA FLOW CYTOMETRY MARKET BY END-USER (USD BILLION), 2020-2029
LIST OF FIGURES
FIGURE 1Â Â Â Â Â Â Â Â Â Â Â Â MARKET DYNAMICS
FIGURE 2Â Â Â Â Â Â Â Â Â Â Â Â MARKET SEGMENTATION
FIGURE 3Â Â Â Â Â Â Â Â Â Â Â Â REPORT TIMELINES: YEARS CONSIDERED
FIGURE 4Â Â Â Â Â Â Â Â Â Â Â Â DATA TRIANGULATION
FIGURE 5Â Â Â Â Â Â Â Â Â Â Â Â BOTTOM-UP APPROACH
FIGURE 6Â Â Â Â Â Â Â Â Â Â Â Â TOP-DOWN APPROACH
FIGURE 7Â Â Â Â Â Â Â Â Â Â Â Â RESEARCH FLOW
FIGURE 8Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL FLOW CYTOMETRY MARKET BY COMPONENT, USD BILLION, 2020-2029
FIGURE 9Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL FLOW CYTOMETRY MARKET BY TECHNOLOGY, USD BILLION, 2020-2029
FIGURE 10Â Â Â Â Â Â Â Â Â Â GLOBAL FLOW CYTOMETRY MARKET BY APPLICATION, USD BILLION, 2020-2029
FIGURE 11Â Â Â Â Â Â Â Â Â Â GLOBAL FLOW CYTOMETRY MARKET BY END-USER, USD BILLION, 2020-2029
FIGURE 12Â Â Â Â Â Â Â Â Â Â GLOBAL FLOW CYTOMETRY MARKET BY REGION, USD BILLION, 2020-2029
FIGURE 13          PORTER’S FIVE FORCES MODEL
FIGURE 14Â Â Â Â Â Â Â Â Â Â FLOW CYTOMETRY MARKET BY COMPONENT 2021
FIGURE 15Â Â Â Â Â Â Â Â Â Â FLOW CYTOMETRY MARKET BY TECHNOLOGY 2021
FIGURE 16Â Â Â Â Â Â Â Â Â Â FLOW CYTOMETRY MARKET BY APPLICATION 2021
FIGURE 17Â Â Â Â Â Â Â Â Â Â FLOW CYTOMETRY MARKET BY END-USER 2021
FIGURE 18Â Â Â Â Â Â Â Â Â Â FLOW CYTOMETRY MARKET BY REGION 2021
FIGURE 19Â Â Â Â Â Â Â Â Â Â MARKET SHARE ANALYSIS
FIGURE 20Â Â Â Â Â Â Â Â Â Â AGILENT TECHNOLOGIES INC.: COMPANY SNAPSHOT
FIGURE 21Â Â Â Â Â Â Â Â Â Â BECTON DICKINSON AND COMPANY: COMPANY SNAPSHOT
FIGURE 22          BIOMÉRIEUX SA: COMPANY SNAPSHOT
FIGURE 23Â Â Â Â Â Â Â Â Â Â BIO-RAD LABORATORIES INC.: COMPANY SNAPSHOT
FIGURE 24Â Â Â Â Â Â Â Â Â Â DANAHER CORPORATION: COMPANY SNAPSHOT
FIGURE 25Â Â Â Â Â Â Â Â Â Â DIASORIN S.P.A.: COMPANY SNAPSHOT
FIGURE 26Â Â Â Â Â Â Â Â Â Â MILTENYI BIOTEC INC.: COMPANY SNAPSHOT
FIGURE 27Â Â Â Â Â Â Â Â Â Â SARTORIUS AG: COMPANY SNAPSHOT
FIGURE 28Â Â Â Â Â Â Â Â Â Â SYSMEX CORPORATION: COMPANY SNAPSHOT
FIGURE 29Â Â Â Â Â Â Â Â Â Â THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
FAQ
The global Flow cytometry market revenue is projected to expand at a CAGR of 7.6% during the forecast period.
The global Flow cytometry market was valued at USD 4.28 Billion in 2020.
Some key players operating in the flow cytometry market include Agilent Technologies Inc., Becton Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories Inc., Danaher Corporation, DiaSorin S.p.A., Miltenyi Biotec Inc., Sartorius AG, Sysmex Corporation, Thermo Fisher Scientific Inc.
Key factors driving the flow cytometry market growth include the rising R&D investments in the biotechnology sector and technological advancements in the field of flow cytometry for introducing new and improved analytical tools, such as microfluidic flow cytometry, for point-of-care testing.
North America region will lead the global flow cytometry market during the forecast period 2022 to 2029.
In-Depth Database
Our Report’s database covers almost all topics of all regions over the Globe.
Recognised Publishing Sources
Tie ups with top publishers around the globe.
Customer Support
Complete pre and post sales
support.
Safe & Secure
Complete secure payment
process.